Literature DB >> 8587244

Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo.

C Hugo1, R Pichler, R Meek, K Gordon, T Kyriakides, J Floege, P Bornstein, W G Couser, R J Johnson.   

Abstract

Thrombospondin 1 has been shown to be linked to PDGF-mediated mesangial cell proliferation and migration in vitro, but little is known regarding its expression or regulation in glomerular disease. Experimental mesangial proliferative nephritis was induced in rats by injection of anti-Thy1 antibody. Mesangial cell proliferation was associated with de novo expression of thrombospondin 1 mRNA (detected by Northern blot and in situ hybridization) and protein (by Western blot and immunostaining). Although some thrombospondin 1 was expressed by platelets and macrophages, double labeling showed that most thrombospondin 1 mRNA and protein were expressed by proliferating alpha-actin-positive mesangial cells. Thrombospondin 1 expression in anti-Thy1 nephritis was complement-dependent and could be reduced by treatment with anti-PDGF or anti-bFGF antibodies. Thrombospondin 1 could also be induced in normal rats by infusion of PDGF and in rats which were primed with low dose anti-Thy1 antibody by infusion of PDGF of bFGF. Thus, this study demonstrates that proliferating mesangial cells express thrombospondin 1 de novo in disease and that thrombospondin 1 expression in vivo is regulated by PDGF and bFGF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587244     DOI: 10.1038/ki.1995.483

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus.

Authors:  C Hugo; S J Shankland; D F Bowen-Pope; W G Couser; R J Johnson
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Platelets are relevant mediators of renal injury induced by primary endothelial lesions.

Authors:  Claudia Schwarzenberger; Jan Sradnick; Kenneth M Lerea; Michael S Goligorsky; Bernhard Nieswandt; Christian P M Hugo; Bernd Hohenstein
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-01

3.  Purinergic signaling induces thrombospondin-1 expression in astrocytes.

Authors:  Minh D Tran; Joseph T Neary
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

5.  Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Authors:  Erika Guise; Jason E Engel; Maxx L Williams; Fakhri Mahdi; Gene L Bidwell; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

6.  Myocilin promotes substrate adhesion, spreading and formation of focal contacts in podocytes and mesangial cells.

Authors:  Andreas Goldwich; Michael Scholz; Ernst R Tamm
Journal:  Histochem Cell Biol       Date:  2008-10-15       Impact factor: 4.304

7.  The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.

Authors:  C Hugo; C Hugo; R Pichler; K Gordon; R Schmidt; M Amieva; W G Couser; H Furthmayr; R J Johnson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Thrombospondin 1 Suppresses Insulin Signaling in C2C12 Myotubes.

Authors:  Kaku Matsugi; Tetsuya Hosooka; Kazuhiro Nomura; Wataru Ogawa
Journal:  Kobe J Med Sci       Date:  2016-06-16

9.  Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo.

Authors:  Christoph Daniel; Yoshitugu Takabatake; Masayuki Mizui; Yoshitaka Isaka; Hiroshi Kawashi; Harald Rupprecht; Enyu Imai; Christian Hugo
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.

Authors:  J W Pippin; Q Qu; L Meijer; S J Shankland
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.